Go Pro
LON:IDH

Immunodiagnostic Systems (IDH) Share Price, News & Analysis

Immunodiagnostic Systems logo

About Immunodiagnostic Systems Stock (LON:IDH)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
14,539 shs
Market Capitalization
£108.80 million
P/E Ratio
290.77
Dividend Yield
0.50%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. The company provides its products and services for diagnosis of bone metabolism, calcium metabolism, hypertension, chronic kidney disease mineral bone disorder, growth, fertility, autoimmunity, infectious disease, sarcoidosis, and allergy. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom.

Receive IDH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Immunodiagnostic Systems and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IDH Stock News Headlines

EQS-News: DATAGROUP Acquires ISC Innovative Systems Consulting AG
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
IDH.L Regulatory News
See More Headlines

IDH Stock Analysis - Frequently Asked Questions

Immunodiagnostic Systems Holdings PLC (LON:IDH) issued its earnings results on Wednesday, June, 20th. The company reported $5.70 earnings per share for the quarter, beating analysts' consensus estimates of $2.60 by $3.10.

Shares of IDH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Immunodiagnostic Systems investors own include Dechra Pharmaceuticals (DPH), iShares Biotechnology ETF (IBB), Redrow (RDW), Netflix (NFLX), Sysco (SYY), TP ICAP Group (TCAP) and Telford Homes (TEF).

Company Calendar

Last Earnings
6/20/2018
Today
8/05/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Medical Appliances & Equipment
Sub-Industry
N/A
Current Symbol
LON:IDH
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
290.77
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
6.84
Current Ratio
5.40
Quick Ratio
3.87

Sales & Book Value

Annual Sales
£34.25 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
4.50
Book Value
GBX 187.60 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
28,784,000
Free Float
N/A
Market Cap
£108.80 million
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (LON:IDH) was last updated on 8/5/2026 by MarketBeat.com Staff.
From Our Partners